Das Asha 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Feb 5, 2019
Insider Transaction Report
Form 4
Das Asha
Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2019-02-01+125,000→ 125,000 totalExercise: $4.56Exp: 2029-02-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]5yr 20% On Vest beginning on 01-Feb-2019